GNH USA

Europe — EMA

Metotrexato Doc Generici

GNH USA supplies Metotrexato Doc Generici (Methotrexate), an immunosuppressant for rheumatoid arthritis, psoriasis and cancers. Request a quote for supply.

Methotrexate

Request sourcing

1
Pack/s

What is Methotrexate?

Methotrexate, the active ingredient in Metotrexato Doc Generici, is an antifolate presented as a generic injectable formulation for subcutaneous use. It treats rheumatoid arthritis, psoriasis and certain cancers in adult patients.

GNH USA supplies Metotrexato Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Methotrexate used for?

Methotrexate is employed in autoimmune and oncologic conditions where inhibition of folate metabolism is required.

Rheumatoid arthritis: reduces joint inflammation and slows disease progression. Psoriasis: decreases skin cell proliferation and improves plaque lesions. Acute lymphoblastic leukemia: interferes with malignant cell replication and supports remission. Non‑Hodgkin lymphoma: contributes to tumor control as part of combination therapy.

What are the side effects of Methotrexate?

Methotrexate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Fatigue or malaise. - Mouth sores (stomatitis). - Elevated liver enzymes. - Low blood cell counts. - Hair thinning.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or interstitial pneumonitis. - Bone marrow failure leading to pancytopenia. - Acute kidney injury. - Life‑threatening infections. - Severe skin reactions such as Stevens‑Johnson syndrome.

What precautions apply to Methotrexate?

Methotrexate requires careful monitoring and patient education.

Monitor liver function: perform baseline and periodic liver enzyme tests. Assess renal function: adjust dose or avoid use if creatinine clearance is reduced. Screen for infections: avoid initiating therapy in active infections. Pregnancy considerations: contraindicated in pregnancy due to teratogenic risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Methotrexate interact with?

Methotrexate interacts with several medicines that can alter its safety profile.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Trimethoprim‑sulfamethoxazole: increased myelosuppression. - Live vaccines: heightened infection risk. - NSAIDs: may exacerbate renal toxicity.

Moderate Interactions (Monitor Closely): - Penicillins: can raise methotrexate plasma levels. - Proton pump inhibitors: may affect renal clearance. - Alcohol: can worsen liver toxicity.

Frequently asked questions

What is Metotrexato Doc Generici used for?+
Metotrexato Doc Generici is a generic methotrexate product indicated for the treatment of rheumatoid arthritis, moderate to severe plaque psoriasis, and certain malignancies such as acute lymphoblastic leukemia and non‑Hodgkin lymphoma. It functions as an immunosuppressant and antineoplastic agent under prescription.
How does methotrexate work?+
Methotrexate blocks the enzyme dihydrofolate reductase, reducing tetrahydrofolate production needed for purine and pyrimidine synthesis. This halts DNA, RNA and protein formation in rapidly dividing cells, providing immunosuppressive and anti‑cancer effects.
What is the usual dose of Metotrexato Doc Generici?+
The dosage of methotrexate is individualized by the prescribing clinician based on the specific indication, patient weight, renal function and treatment response. Regimens may range from low‑dose weekly injections for autoimmune disease to higher doses given in cycles for oncology, and must follow the prescriber’s instructions.
Is Metotrexato Doc Generici safe during pregnancy or breastfeeding?+
Methotrexate is teratogenic and contraindicated in pregnancy because it can cause fetal malformations and miscarriage. Breastfeeding is also discouraged, as the drug can be excreted in milk and affect the infant. Women of child‑bearing potential should use effective contraception during treatment and for a defined period after discontinuation.
How do I order Metotrexato Doc Generici from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if needed—and the necessary import documentation.
How does methotrexate compare with other immunosuppressants?+
Compared with biologic agents such as TNF‑α inhibitors, methotrexate is a small‑molecule drug that is less costly and can be administered by injection or orally. While biologics target specific cytokines, methotrexate has a broader mechanism affecting cell proliferation, which can be advantageous in certain patients but may carry a higher risk of systemic toxicity requiring regular monitoring.
What are the storage and handling requirements for Metotrexato Doc Generici?+
The product should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use, and allow it to reach room temperature briefly before subcutaneous administration, following aseptic technique.
How is Metotrexato Doc Generici administered?+
Metotrexato Doc Generici is supplied for subcutaneous injection. The prescribed dose is drawn into a sterile syringe and injected into the subcutaneous tissue, typically in the abdomen or thigh, using proper aseptic technique. Administration is usually performed once weekly for autoimmune conditions, or as part of a chemotherapy cycle for oncologic indications, as directed by the healthcare provider.
What are the most serious risks associated with methotrexate therapy?+
The most critical risks include severe liver toxicity, pulmonary fibrosis, bone‑marrow suppression leading to pancytopenia, and renal impairment. These adverse events can be life‑threatening and require regular laboratory monitoring, prompt recognition of symptoms, and immediate medical attention if they occur.
Who should not use Metotrexato Doc Generici?+
Patients with known hypersensitivity to methotrexate or any component of the formulation, those with severe renal or hepatic impairment, active infections, or pregnant and breastfeeding women should not receive this medication. Additionally, individuals receiving live vaccines or with uncontrolled immune disorders should avoid its use unless specifically directed by a specialist.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Methotrexate
Route
Subcutaneous Use
Manufacturer
Doc Generici S.R.L.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU